"RSV Vaccine Linked to Rare Nervous System Disorder in Elderly"

Health officials are investigating a potential link between new RSV vaccines and cases of Guillain-Barre syndrome, a rare nervous system disorder, in older adults. The inquiry comes after more than 20 cases were reported among over 9.5 million vaccine recipients, prompting further investigation to determine if the vaccines are causing the problem. While the data is limited, officials are gathering more information to assess the potential risk. Both Pfizer and GSK, the manufacturers of the vaccines, are conducting safety studies to investigate the possibility of vaccine-related GBS, while CDC officials emphasize that the benefits of vaccination still outweigh the potential risks.